Role of key players in paradigm shifts of prostate cancer bone metastasis

References

• LeeGTKangDIHaYSProstate cancer bone metastases acquire resistance to androgen deprivation via WNT5Aa-mediated BMP-6 inductionBrJ Cancer201411061634164424518599
   PubMed Web of Science ®Google Scholar
• KularJTicknerJChimSMXuJAn overview of the regulation of bone remodelling at the cellular levelClin Biochem2012451286387322465238
   PubMed Web of Science ®Google Scholar
• Tran VanPVigneryABaronRAn electron-microscopic study of the bone-remodeling sequence in the ratCell Tissue Res198222522832927105150
   PubMed Web of Science ®Google Scholar
• MashibaTTurnerCHHiranoTEffects of high-dose etidronate treatment on microdamage accumulation and biomechanical properties in beagle bone before occurrence of spontaneous fracturesBone200129327127811557372
   PubMed Web of Science ®Google Scholar
• CamachoDEPientaKJA multi-targeted approach to treating bone metastasesCancer Metastasis Rev2014332–354555324390423
   PubMed Web of Science ®Google Scholar
• KomarovaSVMathematical model of paracrine interactions between osteoclasts and osteoblasts predicts anabolic action of parathyroid hormone on boneEndocrinology200514683589359515860557
   PubMed Web of Science ®Google Scholar
• GrahamJMAyatiBPHolsteinSAMartinJAThe role of osteocytes in targeted bone remodeling: a mathematical modelPLoS One201385e6388423717504
   PubMed Web of Science ®Google Scholar
• GkotzamanidouMDimopoulosMAKastritisEChristoulasDMoulopoulosLATerposESclerostin: a possible target for the management of cancer-induced bone diseaseExpert Opin Ther Targets201216876176922762409
   PubMed Web of Science ®Google Scholar
• SinderBPSalemiJDOminskyMSCairdMSMariniJCKozloffKMRapidly growing BRTL/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatmentBone20157111512325445450
   PubMed Web of Science ®Google Scholar
• LarsonSRZhangXDumpitRCharacterization of osteoblastic and osteolytic proteins in prostate cancer bone metastasesProstate201373993294023334979
   PubMed Web of Science ®Google Scholar
• YavropoulouMPvan LieropAHHamdyNARizzoliRPapapoulosSESerum sclerostin levels in Paget’s disease and prostate cancer with bone metastases with a wide range of bone turnoverBone201251115315722579776
   PubMed Web of Science ®Google Scholar
• WijenayakaARKogawaMLimHPBonewaldLFFindlayDMAtkinsGJSclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathwayPLoS One2011610e2590021991382
   PubMed Web of Science ®Google Scholar
• Garcia-FontanaBMorales-SantanaSVarsavskyMSclerostin serum levels in prostate cancer patients and their relationship with sex steroidsOsteoporosis Int2014252645651
   PubMed Web of Science ®Google Scholar
• LoganCYNusseRThe Wnt signaling pathway in development and diseaseAnnu Rev Cell Dev Biol20042078181015473860
   PubMed Web of Science ®Google Scholar
• HallCLKangSMacDougaldOAKellerETRole of Wnts in prostate cancer bone metastasesJ Cell Biochem200697466167216447163
   PubMed Web of Science ®Google Scholar
• TsengJCLinCYSuLCFuHHYangSDChuuCPCape suppresses migration and invasion of prostate cancer cells via activation of non-canonical Wnt signallingOncotarget2016725380103802427191743
   PubMedGoogle Scholar
• HallCLDaignaultSDShahRBPientaKJKellerETDICKKOPF-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasisProstate200868131396140418561248
   PubMed Web of Science ®Google Scholar
• ThudiNKMartinCKMurahariSDickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastasesProstate201171661562520957670
   PubMed Web of Science ®Google Scholar
• RobinsonDRZylstraCRWilliamsBOWnt signaling and prostate cancerCurr Drug Targets20089757158018673243
   PubMed Web of Science ®Google Scholar
• DaiJHallCLEscara-WilkeJMizokamiAKellerJMKellerETProstate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanismsCancer Res200868145785579418632632
   PubMed Web of Science ®Google Scholar
• BissonIProwseDMWnt signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristicsCell Res200919668369719365403
   PubMed Web of Science ®Google Scholar
• TaiHCChangACYuHJOsteoblast-derived WNT-induced secreted protein 1 increases VCAM-1 expression and enhances prostate cancer metastasis by down-regulating miR-126Oncotarget20145177589759825277191
   PubMedGoogle Scholar
• KlippELiebermeisterWMathematical modeling of intracellular signaling pathwaysBMC Neurosci20067Suppl 1S1017118154
   PubMedGoogle Scholar
• ColemanRESkeletal complications of malignancyCancer1997808 Suppl158815949362426
   PubMed Web of Science ®Google Scholar
• HoeyRPSandersonCIddonJBradyGBundredNJAndersonNGThe parathyroid hormone-related protein receptor is expressed in breast cancer bone metastases and promotes autocrine proliferation in breast carcinoma cellsBr J Cancer200388456757312592371
   PubMed Web of Science ®Google Scholar
• ShenXFalzonMPTH-related protein modulates PC-3 prostate cancer cell adhesion and integrin subunit profileMol Cell Endocrinol2003199116517712581888
   PubMed Web of Science ®Google Scholar
• HastingsRHAraizaFBurtonDWZhangLBedleyMDeftosLJParathyroid hormone-related protein ameliorates death receptor-mediated apoptosis in lung cancer cellsAm J Physiol Cell Physiol20032856C1429C143612917104
   PubMed Web of Science ®Google Scholar
• TaichmanRSBlood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell nicheBlood200510572631263915585658
   PubMed Web of Science ®Google Scholar
• MundyGRMetastasis to bone: causes, consequences and therapeutic opportunitiesNat Rev Cancer20022858459312154351
   PubMed Web of Science ®Google Scholar
• PowellGJSouthbyJDanksJALocalization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sitesCancer Res19915111305930612032246
   PubMed Web of Science ®Google Scholar
• LiaoJSchneiderADattaNSMcCauleyLKExtracellular calcium as a candidate mediator of prostate cancer skeletal metastasisCancer Res200666189065907316982748
   PubMed Web of Science ®Google Scholar
• QuayleLOttewellPDHolenIBone metastasis: molecular mechanisms implicated in tumour cell dormancy in breast and prostate cancerCurr Cancer Drug Targets201515646948025968899
   PubMed Web of Science ®Google Scholar